Antiretroviral therapy coverage in Cape Verde
Cape Verde: Antiretroviral therapy coverage was 80.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage in Cape Verde, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
The most recent figure for antiretroviral therapy coverage in Cape Verde is 80.0%, measured in 2024.
Compared with earlier readings it is up 3.9% on the previous year and up 50.9% over ten years.
Over the whole period, antiretroviral therapy coverage in Cape Verde peaked at 81.0% in 2021 and was at its lowest, 0.0%, in 2000.
Cape Verde ranks 51st of 143 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage in Cape Verde, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 1.0% | — |
| 2005 | 9.0% | +800.0% |
| 2006 | 14.0% | +55.6% |
| 2007 | 21.0% | +50.0% |
| 2008 | 26.0% | +23.8% |
| 2009 | 26.0% | +0.0% |
| 2010 | 32.0% | +23.1% |
| 2011 | 35.0% | +9.4% |
| 2012 | 42.0% | +20.0% |
| 2013 | 49.0% | +16.7% |
| 2014 | 53.0% | +8.2% |
| 2015 | 52.0% | -1.9% |
| 2016 | 53.0% | +1.9% |
| 2017 | 60.0% | +13.2% |
| 2018 | 68.0% | +13.3% |
| 2019 | 71.0% | +4.4% |
| 2020 | 76.0% | +7.0% |
| 2021 | 81.0% | +6.6% |
| 2022 | 79.0% | -2.5% |
| 2023 | 77.0% | -2.5% |
| 2024 | 80.0% | +3.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 9.7% | 0.0% | 26.0% | 10 |
| 2010s | 51.5% | 32.0% | 71.0% | 10 |
| 2020s | 78.6% | 76.0% | 81.0% | 5 |
Countries ranked near Cape Verde
- 49 South Africa 81.0% compare
- 49 Tajikistan 81.0% compare
- 51 Peru 80.0% compare
- 53 Argentina 79.0% compare
- 53 Guinea-Bissau 79.0% compare
- 53 Lebanon 79.0% compare
- 53 Senegal 79.0% compare
More health data for Cape Verde
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.747 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,578 deaths per 1,000 people (2090)
- Number of infants who die before age 1 6 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -7.87 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0306 units per person (2025)
- Population ages 00-04, male, annual growth rate -8.63 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage in Cape Verde?
- Antiretroviral therapy coverage in Cape Verde was 80.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in Cape Verde?
- The highest recorded value was 81.0% in 2021.
- What is the lowest antiretroviral therapy coverage recorded in Cape Verde?
- The lowest recorded value was 0.0% in 2000.
- How does Cape Verde rank for antiretroviral therapy coverage?
- Cape Verde ranks 51st out of 143 countries with data for 2024.
- Is antiretroviral therapy coverage rising or falling in Cape Verde?
- Over the last ten years it is up 50.9%. The long-run trend across the full record is volatile.
- Where does this Cape Verde data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.